A Clinical Trials Manual From The Duke Clinical Research Institute: Lessons from a Horse Named Jim

Ön Kapak
John Wiley & Sons, 24 Ağu 2011 - 432 sayfa
"The publication of the second edition of this manual comes at an important juncture in the history of clinical research. As advances in information technology make it possible to link individuals and groups in diverse locations in jointly seeking the answers to pressing global health problems, it is critically important to remain vigilant about moral and ethical safeguards for every patient enrolled in a trial. Those who study this manual will be well aware of how to ensure patient safety along with fiscal responsibility, trial efficiency, and research integrity."
Robert Harrington, Professor of Medicine, Director, Duke Clinical Research Institute, Durham, North Carolina, USA

The Duke Clinical Research Institute (DCRI) is one of the world's leading academic clinical research organizations; its mission is to develop and share knowledge that improves the care of patients around the world through innovative clinical research. This concise handbook provides a practical "nuts and bolts" approach to the process of conducting clinical trials, identifying methods and techniques that can be replicated at other institutions and medical practices.

Designed for investigators, research coordinators, CRO personnel, students, and others who have a desire to learn about clinical trials, this manual begins with an overview of the historical framework of clinical research, and leads the reader through a discussion of safety concerns and resulting regulations. Topics include Good Clinical Practice, informed consent, management of subject safety and data, as well as monitoring and reporting adverse events.

Updated to reflect recent regulatory and clinical developments, the manual reviews the conduct of clinical trials research in an increasingly global context. This new edition has been further expanded to include:

  • In-depth information on conducting clinical trials of medical devices and biologics
  • The role and responsibilities of Institutional Review Boards, and
  • Recent developments regarding subject privacy concerns and regulations.

Ethical documents such as the Belmont Report and the Declaration of Helsinki are reviewed in relation to all aspects of clinical research, with a discussion of how researchers should apply the principles outlined in these important documents. This graphically appealing and eminently readable manual also provides sample forms and worksheets to facilitate data management and regulatory record retention; these can be modified and adapted for use at investigative sites.

 

İçindekiler

Foreword by Robert A Harrington
Developing New Drugs Biologics
Good Clinical Practice and the Regulations
Informed Consent and the Regulations
The Principal Investigator the Clinical Research
The Protocol
Reviewing a Specific Protocol
Appendix C
Epilogue by Lisa G Berdan
Telif Hakkı

Diğer baskılar - Tümünü görüntüle

Sık kullanılan terimler ve kelime öbekleri

Yazar hakkında (2011)

Margaret Liu is a clinical trials consultant based in Singapore and former manager of the Monitoring Group at the Duke Clinical Research Institute (DCRI).

Kate Davis is Business Development Specialist for DCRI Communications Group, Durham, NC, US.

Kaynakça bilgileri